Pattern Bioscience Stock

Pattern Bioscience, founded in 2016, is a in-vitro diagnostics company seeking to help combat the problem of antibiotic resistance. The company is developing a clinical microbiology platform based on its patented phenotypic single-cell technology with the goal of identifying pathogens and determining their antibiotic response without the need for traditional time-consuming culture steps. The platform is aiming to deliver more reliable diagnoses days faster than the current standard of care. Pattern Bioscience is headquartered in Austin, Texas.